Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Document › Details

AB Sciex (d/b/a Sciex). (11/9/15). "Press Release: Sciex Launches the CESI 8000 Plus, a High Performance CESI-MS Platform that delivers High Resolution and Ionization Efficiency". Framingham, MA.

Organisation Organisation AB Sciex (Danaher, Framingham, MA)
  Group Danaher (Group)
Products Product CESI 8000 Plus system
  Product 2 CESI-MS technology
Persons Person Plohetski, John W. (Danaher 201511 Global VP Separations at Sciex before Thermo Fisher)
  Person 2 Sicurella, Stacey (Danaher 201503 Manager Global PR + Brand for Sciex)

SCIEX, a global leader in life science analytical technologies, today introduced the CESI 8000 Plus, their next generation CESI-MS platform. This new platform further advances CESI-MS, enabling multiple experiments to be generated from as little as 5 microlitres (µL) of starting material. Combining this capability with the multi-segment injection methodology, one can process ten experiments in the time it would normally take to process one, with less than 1 µL consumed. This system is ideal for experiments where samples are limited, including microdialysates, needle biopsies, FFPE archives, rare circulating tumor cells, or where samples are highly toxic. In addition, the innovation of neutral capillary surfaces further reduces system flow to less than 10 nanolitres/min (nL/min). The CESI 8000 Plus delivers higher resolution separations, improved ionization efficiency and reduced ion suppression. Optional Laser-induced Fluorescence, Diode-Array and Selectable Wavelength UV detector modules are available, enabling off-line method development capability on this platform.

The CESI 8000 Plus enables the separation of intact protein isoforms followed by mass spectrometry for researchers who need to understand the critical characteristics of biotherapeutics in development. CESI-MS provides a liquid-phase ion mobility separation, which now makes it possible to resolve closely related proteoforms, glycoforms, phosphorylated species and other post translational modifications (PTMs) on proteins.

For academics, the OptiMS neutral capillary cartridge enables researchers to map and separate complex proteomes using either protein digest or intact protein strategies. For the first time, Enzymes, Protein-Protein and receptor-ligand complexes can now be investigated with high resolution separation in a native state, to study their structure/function relationships with mass spectrometry. Metabolomics researchers can take advantage of a single platform for analysis of both negatively and positively charged metabolites, allowing the automated analysis of these analytes without having to change columns or reagents.

"When SCIEX introduced CESI-MS several years ago, we set a new benchmark for the needs of biopharma scientists, and now the CESI 8000 Plus represents another break-through for scientists working in other applications." said John Plohetski, Global Vice President, Separations at SCIEX. "Combined with the unique separation selectivity and enhanced sensitivity, our customers are utilizing the CESI 8000 Plus to get more information from precious samples that may only be available in limited quantity, and they are identifying proteins and protein modifications never before reported."

Learn more about the CESI 8000 Plus System


SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.

With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit

SCIEX social: Twitter, LinkedIn, and on Facebook.

For research use only. Not for use in diagnostic procedures. RUO-MKT-12-2613

AB Sciex is operating as SCIEX.
© 2015 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.

Contact Information

Stacey Sicurella
Public Relations and Brand Manager, Global Marketing

Editorial follow-up
Patrick Farrell
Sniper Public Relations on Behalf of SCIEX


Record changed: 2016-01-10


Picture Fairtec GmbH Worldwide Event Solutions 650x65px

More documents for Danaher (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px

» top